GSK And Takeda Boost Arrowhead’s Coffers, But In-House Results Crucial To Gene Silencing Platform
Can RNAi Work In The Lung?
Arrowhead is hoping for proof-of-concept data in lung disease and cholesterol lowering candidates in Q2. • Source: Shutterstock 
